Opko Health Inc (OPK)
$4.22 0.03 (0.72%)
19:59 EST OPK Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 2.36B
PE Ratio -7.40
Volume (Avg. Vol.) 10.49M
Day's Range 3.83 - 4.23
52-Week Range 1.12 - 6.47
Dividend & Yield N/A (N/A)
OPK Stock Predictions, Articles, and Opko Health Inc News
- From InvestorPlace
- From the Web
These seven penny stocks are most likely to push through the $5 mark having built a significant head of steam in the past year.
Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity. Let's look at some.
Opko is generating strong revenue from testing for the coronavirus, while its HGH drug looks quite promising. As a result, OPK stock is a buy.
Opko is conducting a coronavirus treatment study, as well as providing Covid-19 tests. That gives OPK stock two ways to play the virus.
Market watchers are looking to the insiders, hoping insights from their activity can steer them towards returns.
Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.
OPKO Health (OPK) news for Friday concerning new testing for the coronavirus from China in New York has OPK stock soaring higher.
Opko Health (OPK) is seeing OPK stock head higher on Friday following an announcement concerning a test for the coronavirus from China.
Stock charts of AAPL, PG and SCG have earned a closer look from traders as today's session gets started.
The stock charts of PCG, WY and ORCL are run through the technical trading wringer. Here's the next likely move for all three.
With shares nearly double where they were in May, OPKO Health, Inc. (NASDAQ:OPK) needed a strong second-quarter earnings report to justify the gains in OPKO....
Nvidia (NVDA) options jump on Bosch deal, Bernstein believes in Netflix (NFLX) and Opko Health (OPK) initiated at Guggenheim.
Analysts see Rite Aid (RAD), Chesapeake Energy (CHK) and Opko Health (OPK) as three cheap stocks to buy with major near-term upside.
Facebook (FB) eyes streaming video, Opko Health (OPK) options spike amid kidney drug release and Nvidia (NVDA) upgraded at Evercore ISI.
This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
From Market News Video
Navellier RatingsPowered by Portfolio Grader